128 related articles for article (PubMed ID: 18156308)
1. Chemoprevention of arylamine-induced colorectal aberrant crypts.
Feng Y; Neale JR; Doll MA; Hein DW
Exp Biol Med (Maywood); 2008 Jan; 233(1):71-5. PubMed ID: 18156308
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
3. Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2'-dimethyl-4-aminobiphenyl.
Feng Y; Finley JW; Davis CD; Becker WK; Fretland AJ; Hein DW
Toxicol Appl Pharmacol; 1999 May; 157(1):36-42. PubMed ID: 10329505
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib.
Ravoori S; Feng Y; Neale JR; Jeyabalan J; Srinivasan C; Hein DW; Gupta RC
Mutat Res; 2008 Feb; 638(1-2):103-9. PubMed ID: 17950762
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
8. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl.
Feng Y; Fretland AJ; Rustan TD; Jiang W; Becker WK; Hein DW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):56-62. PubMed ID: 9356307
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
10. Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of rats.
Buecher B; Thouminot C; Menanteau J; Bonnet C; Jarry A; Heymann MF; Cherbut C; Galmiche JP; Blottière HM
Reprod Nutr Dev; 2003; 43(4):347-56. PubMed ID: 14971826
[TBL] [Abstract][Full Text] [Related]
11. Dietary copper, manganese and iron affect the formation of aberrant crypts in colon of rats administered 3,2'-dimethyl-4-aminobiphenyl.
Davis CD; Feng Y
J Nutr; 1999 May; 129(5):1060-7. PubMed ID: 10222400
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci.
Kim KP; Whitehead C; Piazza G; Wargovich MJ
Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359
[TBL] [Abstract][Full Text] [Related]
13. Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
Kim JY; Alam F; Chung SW; Park J; Jeon OC; Kim SY; Son WC; Byun Y
Anticancer Drugs; 2014 Oct; 25(9):1061-71. PubMed ID: 25003253
[TBL] [Abstract][Full Text] [Related]
14. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
[TBL] [Abstract][Full Text] [Related]
15. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
[TBL] [Abstract][Full Text] [Related]
16. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
17. Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer.
Vaish V; Piplani H; Rana C; Sanyal SN
Cell Biochem Biophys; 2013 Jun; 66(2):205-27. PubMed ID: 23149858
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
Márquez-Rosado L; Trejo-Solís MC; García-Cuéllar CM; Villa-Treviño S
J Hepatol; 2005 Oct; 43(4):653-60. PubMed ID: 16023763
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model.
Shpitz B; Giladi N; Sagiv E; Lev-Ari S; Liberman E; Kazanov D; Arber N
Digestion; 2006; 74(3-4):140-4. PubMed ID: 17228149
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids.
Lu S; Zhang X; Badawi AF; El-Sohemy A; Archer MC
Cancer Lett; 2002 Oct; 184(1):7-12. PubMed ID: 12104042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
